Image for post
Image for post
The FDA is approving more drugs for rare diseases each year than ever before.

When politics, climate change or international conflicts have me down, I turn to biotech instead. There’s always a new scientific discovery, a new drug for a rare disease, a new medical device for a common ailment.

But non-industry media under-reports good news in biotech. Many biomedical stories that do go mainstream are inaccurate.

Here are ten real biomedical wins from 2018 (with a contentious #10):

So whatever else happened in 2018, the biomedical endeavor continues its steady progress, to the benefit of us all.


*Disclosure: I’ve owned shares in starred companies within the past 12 months.

Principal, RA Capital. Serve on boards of 6 biotech companies. Ex-Founder/CEO of Nivien Therapeutics. Writing is my own.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store